These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18838590)

  • 21. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review: phage therapy: a modern tool to control bacterial infections.
    Qadir MI
    Pak J Pharm Sci; 2015 Jan; 28(1):265-70. PubMed ID: 25553704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
    Segall AM; Roach DR; Strathdee SA
    Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profile of Paul E. Turner.
    Viegas J
    Proc Natl Acad Sci U S A; 2020 Aug; 117(32):18906-18908. PubMed ID: 32747551
    [No Abstract]   [Full Text] [Related]  

  • 26. A bacteriophage journey at the European Medicines Agency.
    Debarbieux L; Pirnay JP; Verbeken G; De Vos D; Merabishvili M; Huys I; Patey O; Schoonjans D; Vaneechoutte M; Zizi M; Rohde C
    FEMS Microbiol Lett; 2016 Jan; 363(2):fnv225. PubMed ID: 26656541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection and Characterization of Phage-Resistant Mutant Strains of Listeria monocytogenes Reveal Host Genes Linked to Phage Adsorption.
    Denes T; den Bakker HC; Tokman JI; Guldimann C; Wiedmann M
    Appl Environ Microbiol; 2015 Jul; 81(13):4295-305. PubMed ID: 25888172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phage Therapy: Going Temperate?
    Monteiro R; Pires DP; Costa AR; Azeredo J
    Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
    Mirski T; Lidia M; Nakonieczna A; Gryko R
    Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phage therapies for plants and people.
    Gross M
    Curr Biol; 2014 Jun; 24(12):R541-4. PubMed ID: 25075391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriophage biocontrol to fight Listeria outbreaks in seafood.
    Lasagabaster A; Jiménez E; Lehnherr T; Miranda-Cadena K; Lehnherr H
    Food Chem Toxicol; 2020 Nov; 145():111682. PubMed ID: 32805341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy.
    Bull JJ; Levin BR; Molineux IJ
    Viruses; 2019 Nov; 11(12):. PubMed ID: 31766537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
    Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
    J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing the Timing and Composition of Therapeutic Phage Cocktails: A Control-Theoretic Approach.
    Li G; Leung CY; Wardi Y; Debarbieux L; Weitz JS
    Bull Math Biol; 2020 Jun; 82(6):75. PubMed ID: 32533350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary Rationale for Phages as Complements of Antibiotics.
    Torres-Barceló C; Hochberg ME
    Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biotechnological applications of bacteriophages: State of the art.
    Harada LK; Silva EC; Campos WF; Del Fiol FS; Vila M; Dąbrowska K; Krylov VN; Balcão VM
    Microbiol Res; 2018; 212-213():38-58. PubMed ID: 29853167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience of the Eliava Institute in bacteriophage therapy.
    Kutateladze M
    Virol Sin; 2015 Feb; 30(1):80-1. PubMed ID: 25662889
    [No Abstract]   [Full Text] [Related]  

  • 39. Kinetics of phage-mediated biocontrol of bacteria.
    Abedon ST
    Foodborne Pathog Dis; 2009 Sep; 6(7):807-15. PubMed ID: 19459758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriophages as an alternative strategy for fighting biofilm development.
    Parasion S; Kwiatek M; Gryko R; Mizak L; Malm A
    Pol J Microbiol; 2014; 63(2):137-45. PubMed ID: 25115107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.